CDEK
← All organizations

L'Oreal

For profitContributed to NMEWebsite ↗

Also known as: CeraVe | L'Oreal | Loreal USA | LOREAL USA

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jun 1, 2004

First marketed drug

Jul 21, 2006

First NDA

Jul 21, 2006

Last known activity

Sep 27, 2024

Acquired by Sanofi-Synthelabo → Sanofi-Aventis on Jun 1, 1999

Timeline

1900s

  1. Jul 30, 1909

    L'Oreal— Founded

1970s

  1. Jan 1, 1973

    Synthelabo— Acquired

1990s

  1. Jun 1, 1999

    Sanofi-Synthelabo— Acquired By

2000s

  1. Jan 1, 2004

    Sanofi-Aventis— Now

  2. Jul 21, 2006

    octocrylene— NDA Secondary Org

  3. Jul 21, 2006

    ecamsule— NDA Organization

Drugs by trial phase (18 distinct, 15 trials)

Phase 4 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (4)

Subsidiaries (1 direct, 4 total across the full acquisition tree)

Recent trials (17)

Details

Founded
Clichy, FR Jul 30, 1909
First NDA
Jul 21, 2006
Last known activity
Sep 27, 2024